Skip to main content

Advertisement

Table 14 Antibacterial activity (zone of inhibition = mm) of most active compounds

From: Therapeutic potential of heterocyclic pyrimidine scaffolds

S. no Pathogens a29 a30 Bacitracin Ciprofloxacin
1 Citrobacter sp. 37.16 ± 0.15 28.66 ± 0.15 0.00 ± 0.00 19.62 ± 0.18
2 Escherichia coli 36.66 ± 0.15 27.83 ± 0.20 0.00 ± 0.00 0.00 ± 0.00
3 Klebsiella sp. 32.50 ± 0.13 25.50 ± 0.27 0.00 ± 0.00 20.25 ± 0.16
4 Proteus mirabilis 28.66 ± 0.25 23.33 ± 0.17 0.00 ± 0.00 18.25 ± 0.16
5 Pseudomonas aeruginosa 30.66 ± 0.12 27.83 ± 0.27 0.00 ± 0.00 34.25 ± 0.16
6 S. parathyphi A 34.66 ± 0.12 24.50 ± 0.12 0.00 ± 0.00 27.75 ± 0.16
7 S. parathyphi B 32.50 ± 0.13 27.83 ± 0.20 0.00 ± 0.00 27.63 ± 0.18
8 Salmonella typhi 29.50 ± 0.25 19.66 ± 0.11 0.00 ± 0.00 20.25 ± 0.16
9 S. typhimurium 34.66 ± 0.12 23.33 ± 0.17 0.00 ± 0.00 18.75 ± 0.31
10 Shigella boydii 37.50 ± 0.07 28.66 ± 0.25 0.00 ± 0.00 17.75 ± 0.16
11 Shigella flexneri 35.66 ± 0.08 25.50 ± 0.27 0.00 ± 0.00 27.63 ± 0.18
12 Shigella sonnei 32.50 ± 0.13 37.50 ± 0.07 0.00 ± 0.00 21.75 ± 0.16
13 Staphylococcus aureus 37.50 ± 0.07 32.50 ± 0.13 26.75 ± 0.84 18.13 ± 0.48
14 Streptococcus faecalis 38.50 ± 0.12 35.66 ± 0.08 0.00 ± 0.00 0.00 ± 0.00